STOCK TITAN

BBLN - BBLN STOCK NEWS

Welcome to our dedicated page for BBLN news (Ticker: BBLN), a resource for investors and traders seeking the latest updates and insights on BBLN stock.

Babylon Holdings Limited, marked with the stock symbol BBLN, is the United Kingdom's leading digital healthcare service provider. Founded in January 2013 and publicly launched in April 2014, the company aims to democratise healthcare by making it accessible and affordable for everyone globally. Babylon has assembled one of the largest teams of scientists, clinicians, mathematicians, and engineers to integrate advanced computational power with top-tier medical expertise. This synergy aims to deliver a comprehensive, immediate, and personalised health service universally.

Babylon is regulated by the Care Quality Commission (CQC) and offers users immediate access to General Medical Council (GMC) registered doctors and British Association for Counselling and Psychotherapy (BACP) registered therapists. The company’s services are now available to over 800,000 people globally, with localized operations in the U.K., Ireland, and a recent expansion to new markets.

Babylon's core business revolves around its digital healthcare platform, which combines artificial intelligence and human medical expertise. This platform provides a range of services, including virtual consultations, health assessments, and real-time monitoring of medical conditions. The company's mission is to make quality healthcare services immediately accessible to all, thereby reducing the burden on traditional healthcare systems.

In terms of recent achievements, Babylon has been continuously innovating its service offerings, expanding its geographical footprint, and forging significant partnerships. These strategic moves aim to enhance user experience and widen the availability of its digital healthcare services. With a solid financial footing and ambitious projects in the pipeline, Babylon is well-positioned to sustain its leadership in the digital healthcare domain.

Stay tuned for the latest updates and news, as Babylon continues to transform the way healthcare is delivered worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.19%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-71.05%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-71.05%
Tags
none
-
Rhea-AI Summary

Babylon (NYSE: BBLN) will host a conference call on May 10, 2023, at 8:00 AM Eastern Time, to discuss its first quarter financial results. A press release detailing the results will be available before the call. Participants can join by dialing (877) 407-7994 for the U.S., 0 800 756 3429 for the U.K., or +1 215-268-9868 internationally. Alternatively, the call will be accessible via a live webcast at babylonhealth.com. Babylon aims to revolutionize healthcare accessibility through its digital primary care services across 15 countries, supporting a diverse patient network and operational capabilities in 16 languages.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.12%
Tags
-
Rhea-AI Summary

Babylon (NYSE: BBLN) has launched personalized, digital-first programs for high-risk members with chronic conditions, including diabetes, hypertension, and prenatal care. These initiatives are designed to provide evidence-based, real-time monitoring and support through integrated care teams. The company's technology gathers data to enhance patient engagement and health management. Babylon aims to improve health outcomes while reducing acute events and hospitalizations.

With a focus on empowering patients, Babylon's programs offer tailored care plans and ongoing support, particularly for underserved populations in rural areas. The company continues to expand its services globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.28%
Tags
none
Rhea-AI Summary

Babylon Holdings Limited (NYSE: BBLN) reported significant financial growth for 2022, with revenue rising 3.5x year-over-year to $1.11 billion. The U.K. clinical services achieved profitability, and U.S. clinical services are expected to follow suit early in 2023. Key U.S. value-based care (VBC) contracts generated profitable medical margins in their first year. While Q4 2022's adjusted EBITDA was $(16.3) million, it outperformed expectations. The company anticipates achieving adjusted EBITDA profitability by mid-2024, earlier than previously forecasted. Babylon also introduced a new digital-first Commercial Exchange product, expanding its VBC membership significantly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.66%
Tags
none
-
Rhea-AI Summary

Babylon (NYSE: BBLN) will host a conference call on March 9, 2023, at 8:00 AM ET to discuss its fourth quarter and full year 2022 financial results. The company will issue a press release with the results prior to the call. Participants can join by dialing specified numbers for U.S., U.K., and international attendees or by accessing the live webcast on the Babylon investor relations website. Babylon is committed to making healthcare accessible globally, leveraging its digital-first primary care services across 15 countries and supporting operations in 16 languages.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.41%
Tags
-
Rhea-AI Summary

Babylon Holdings Limited (NYSE: BBLN) anticipates revenue exceeding $1.05 billion for the year ending December 31, 2022, including its California IPA business. The company expects to outperform its previously estimated IFRS Adjusted EBITDA loss of $(270) million. Following cost-cutting measures, Babylon aims for an additional $100 million in annual savings. Transitioning to U.S. GAAP reporting status, the company will announce its Q4 and year-end results under this new format.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.1%
Tags
none
Rhea-AI Summary

Babylon (NYSE: BBLN) has announced a 1-for-25 reverse share split of its Class A ordinary shares, effective December 15, 2022. This measure aims to boost the share price to comply with NYSE minimum requirements and attract institutional investors. Following the split, the share capital will total US$409,896.05, with new par values set at US$0.001056433113 for both Class A and Class B shares. Babylon’s shares will continue trading under the symbol 'BBLN', and fractional shares will be sold, with cash payments made to affected shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
none

FAQ

What is the market cap of BBLN (BBLN)?

The market cap of BBLN (BBLN) is approximately 14.1M.

What does Babylon Holdings Limited do?

Babylon Holdings Limited is a digital healthcare service provider that aims to make healthcare accessible and affordable globally by combining advanced computing power with medical expertise.

When was Babylon founded?

Babylon was founded in January 2013 and launched to the public in April 2014.

What are Babylon's core services?

Babylon offers virtual consultations, health assessments, and real-time monitoring of medical conditions through its digital healthcare platform.

Who regulates Babylon's services?

Babylon's services are regulated by the Care Quality Commission (CQC).

How many people use Babylon's services?

Over 800,000 people globally use Babylon's services.

Where does Babylon operate?

Babylon operates in the U.K., Ireland, and has recently expanded to new markets.

What makes Babylon's healthcare services unique?

Babylon combines artificial intelligence with human medical expertise to provide a comprehensive and personalised healthcare service.

Who can access Babylon's healthcare services?

Anyone can access Babylon's healthcare services, which include immediate consultations with GMC-registered doctors and BACP-registered therapists.

What is Babylon's mission?

Babylon's mission is to democratise healthcare by making it accessible and affordable for every person on earth.

How does Babylon enhance user experience?

Babylon enhances user experience by continuously innovating its service offerings, expanding its geographical footprint, and establishing significant partnerships.

BBLN

NYSE:BBLN

BBLN Rankings

BBLN Stock Data

14.10M
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services
Link